Search

everythinglearnresearchcommunity

for

Search:↓

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

A new compound shows promise as a topical treatment for hair loss.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Apoptosis is crucial for healthy skin and treating skin diseases.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Certain hormone treatments can improve acne and related conditions in women.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.